chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had 5 seizures with in 36 hours 5 days after the first vaccine./Other medical history: Seizures; Had 5 seizures with in 36 hours 5 days after the first vaccine./Other medical history: Seizures; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: ER8727), via an unspecified route of administration on 01Apr2021 13:30 (58-years-old) as single dose for COVID-19 immunization. Medical history included seizure. Patient is not pregnant. Patient had no COVID prior vaccination. Patient was not tested for COVID post vaccination. Concomitant medication included valproate semisodium (DEPAKOTE) for seizure. The patient previously took Paxil and experienced allergies. The patient had 5 seizures within 36 hours 5 days after the first vaccine (06Apr2021 11:45). They had to increase semisodium which has helped keep the seizures at bay. She have not had seizures in two years. Event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of event (Increase in routine medicine). The outcome of the event was recovering.
Patient came in complaining 2 weeks after the vaccine she could not raise her arm, because I had given too high up. I suggested OTC products, she said already done, then I advised dr. She called later the pt had to inject her with steroids she had a case of bursitis due to the injection site.
Started having problems with his eyes after 3 weeks after 2nd Pfizer dose, doesn't know if it's because of vaccine.
Headache that started the following day and had proceeded to get worse; This is a spontaneous report from a contactable consumer (reporting on herself). A 50-years-old Non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection Lot Number: EN6205 and Expiration Date was not reported), via an unspecified route of administration in Arm Right on 04Mar2021 13:00, as 1st dose, single dose for covid-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19, and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that headache that started the following day (on 05Mar2021 at 07:00) and has proceeded to get worse. Adverse event was resulted in Doctor or other healthcare professional office/clinic visit. Patient did not received any treatment. Patient did not tested covid post vaccination. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a dialysis male patient who had received three dose series of hepatitis B virus vaccine (lot # not reported) on unspecified dates. Subsequently the patient was found to be hepatitis B antigen positive. The patient had sought medical attention by dialysis on schedule. At the time of this report, the patient's outcome was unknown. Follow up information has been received from a registered nurse who provided the list of dates the patient was vaccinated and clarification of which vaccine the patient was given, along with dates, lot #'s and expiration dates as below: ENGERIX-B was given on 29-OCT-2009 (lot # AHBVB719AA, expiration date 04-NOV-2011), 01-DEC-2009 (lot # AHBVB632AA, expiration date 13-APR-2011), 29-APR-2010 (lot # AHBV834BA, expiration date 02-JUN-2012), 12-JUN-2010 (lot # not reported) ("same as above by looking at consent") and 15-JUL-2010 (lot # AHBVB798AA, expiration date 27-APR-2012), respectively. Hepatitis B virus vaccine (lot # 669001/1064Z, expiration date 15-APR-2013) was given on 05-APR-2011. Follow up information has been received on 23-JUN-2011 from a physician and medical records concerning a 52 year old male with end stage renal disease (ESRD) at the time of vaccination. The patient was vaccinated with ENGERIX-B was given on 29-OCT-2009 (lot # AHBVB719AA, expiration date 04-NOV-2011), 01-DEC-2009 (lot # AHBVB632AA, expiration date 13-APR-2011), 29-APR-2010 (lot # AHBV834BA, expiration date 02-JUN-2012), 12-JUN-2010 (lot # not reported) and 15-JUL-2010 (lot # AHBVB798AA, expiration date 27-APR-2012), respectively. Hepatitis B virus vaccine (lot # 669001/1064Z, expiration date 15-APR-2013) was given on 05-APR-2011. It was noted that the patient's results of monthly hepatitis 15-APR-2013) was given on 05-APR-2011. It was noted that the patient's results of monthly hepatitis 15-APR-2013) was given on 05-APR-2011. It was noted that the patient's results of montly hepatitis B surface antigen test from 07-JAN-2010 to 10-MAR-2011 were non reactive. On 07-APR-2011, the patient's hepatitis B surface antigen result had been reported as reactive. The patient had persistent positive hepatitis B surface antigen results on 19-APR-2011, 26-APR-2011, 05-MAY-2011 and 31-MAY-2011. On 28-APR-2011 and 09-JUN-2011, the patient's results of HBV DNA were <29 IU/ml and the results of HBV DNA QT were <169 copies/ml. The physician reported the patient had persistent positive hepatitis B surface antigen after the last dose of Hepatitis B virus vaccine. All avilable medical records will be provided upon request. No further information is available.
Diagnosed with Bell's Palsy, left side of face, 4/25/2021.  Started at 0600, diagnosed 21 hours later.  Had chest X-ray, electrocardiogram, blood work, MRI.  Not a stroke.  treated with prednisone and valacyclovir.  after 6 days, the palsy has not cleared up. Immediately after both COVID shots (1/26/21 & 2/26/21) had only minor effects, sore arm. no fever,
Swelling underneath the armpit of the same arm of injection (Pfizer Booster 0.3ml).  The area is very swollen and sore.  Unable to rest arm alongside the body.  Unable to sleep on the side of swelling.  Swelling appears in the form of a knot and is soft (tissue) as opposed to hard (tissue).  Alternating cold and heat packs and taking Tylenol have not reduced the tenderness, swelling, or pain.  The area is very uncomfortable and has lasted for more than 48 hours since injection.
pressure under both eyes that is sporadic; could not read and had blurred vission; Fever; eye pain with blurred vision; not able to get out of bed/arms weak; eyes hurt/ eye pain with blurred vision; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (not able to get out of bed/arms weak), EYE PAIN (eyes hurt/ eye pain with blurred vision), OCULAR DISCOMFORT (pressure under both eyes that is sporadic), READING DISORDER (could not read and had blurred vission) and VISION BLURRED (eye pain with blurred vision) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No allergies, current medical condition or medical history was reported by the reporter.    On 24-Feb-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021 at 8:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced ASTHENIA (not able to get out of bed/arms weak) and EYE PAIN (eyes hurt/ eye pain with blurred vision). On 24-Mar-2021 at 11:00 AM, the patient experienced VISION BLURRED (eye pain with blurred vision). On 24-Mar-2021 at 5:00 PM, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced OCULAR DISCOMFORT (pressure under both eyes that is sporadic) and READING DISORDER (could not read and had blurred vission). On 25-Mar-2021, PYREXIA (Fever) had not resolved. On 29-Mar-2021, VISION BLURRED (eye pain with blurred vision) had resolved with sequelae. At the time of the report, ASTHENIA (not able to get out of bed/arms weak), EYE PAIN (eyes hurt/ eye pain with blurred vision) and OCULAR DISCOMFORT (pressure under both eyes that is sporadic) had not resolved and READING DISORDER (could not read and had blurred vission) outcome was unknown.            No Concomitant medications were provided by the reporter. No treatment details were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Events added, product information updated.
Information has been received from a certified medical assistant referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored doses of COMVAX lot # J013884 with expiration date of ??-AUG-2016; strength, dosage, frequency and route unspecified). The vaccines were exposure in 30F for 20 hours and 53F for 19 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient reports pain and inflammation in the upper and lower arm.  Patient states that pain is so severe it has required 2 doctor visits over the last 2 weeks and has required medication.  Patient did not bring any documentation of these treatments when reporting to pharmacy/administrator.
I had a sore arm for a couple of days after receiving the vaccine. I didn't feel good with cold like symptoms and I tested positive for COVID-19 in 12/2022. I contacted my nurse practitioner and got a prescription for PAXLOVID. I tolerated the medication without any difficulty. As of today, I have not lingering symptoms of COVID-19.
died from Guillian Barre syndrome; Initial information received on 13-Feb-2022 regarding an unsolicited valid Social Media serious case received from consumer/non-hcp.  This case involves an unknown age male patient who died from guillian barre syndrome, after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect  Influenza Vaccine produced by unknown manufacturer (unknown dose, formulation lot number, via unknown route in unknown administration site) as prophylactic vaccination.  On an unknown date, the patient died from guillian barre syndrome (guillain-barre syndrome) (unknown latency) .This event was assessed as medically significant and was leading to death.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (died from Guillian Barre syndrome).  At time of reporting, the outcome was Fatal for the event died from guillian barre syndrome. It is unknown if an autopsy was done. The cause of death was reported as Guillain Barre syndrome.; Sender's Comments: Sanofi company comment dated 17-Feb-2022: This case involves a male patient of unknown age who died from Guillian Barre syndrome after vaccination with influenza Vaccine (Manufacturer unknown). The time to onset is not reported with the role of the vaccine. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed.; Reported Cause(s) of Death: died from Guillian Barre syndrome
Within minutes of receiving the injection, I developed a metallic taste in my mouth. I also felt a bit light-headed and woozy. I informed the staff at the site that I felt this way and they asked me to remain for additional monitoring. Over the next 15 minutes, my tongue began to swell. 15 minutes later my jaw began to stiffen and I had difficulty swallowing. After another 15 minutes the staff asked the EMS personnel to screen me and check my vitals. All were normal. After another 30 minutes of monitoring by EMS the symptoms began to subside and I went home.   At home, I began to feel weak and went to bed. My body began to ache and I took ibuprofen to ease the pain. Within 15 hours of receiving the dose, I had a 100.9-degree fever and chills. The fever lasted the next day. I could not get out of bed for the next day. When I tried to sit up and watch TV I had back pain so severe it left me in tears.  I went back to bed and stayed there until the following morning. All told, I could not get out of bed for 36 hours.
Started slight rash on Thursday progress until Sat examine by Home Hlth Ns Sat. Hives. Given Benadryl. By Sun p/noon, no fever or malaise.
Fever, myalgias, headache, chills, sore throat, chest tightness, hand's tingling. Seen @ Hospital ER on 5/31/06.
Patient presents to discuss a medication error. The patient was given dose 1 of MODERNA on 4/11/21 at PDX at age 15. This error was not logged at the time, and clinic staff were not made aware of this, representing multiple system failures. The patient returned today at 28 days for his 2nd dose of MODERNA. We reviewed the error with the patient and his parents in detail. A detailed risk/benefit discussion was had between family, patient, clinical site lead, pharmacy, and site lead. Of note, the patient's father is a physician. In a review of all available options, the choice was made to give the 2nd dose of MODERNA today. The patient is healthy near 16 years old of healthy weight, and it was felt the risk of COVID19 outweighed any risk related to vaccination.
Started end of March, numbness, tingling, legs collapse falling: Numbness from chest down. Loss of bowels and dead bladder. Almost paralyzed. Unsteady walking. Arms, hands tingle. Ongoing catheters daily. Had IVIG 5 days May 2014. Patient has no feeling in legs and feet; But they hurt all time. It feels like needles and ice picks sticking him at all times. Patient can't tell how high to lift his feet, resulting in falling and stumbling.
A couple days later, I started feeling stomach pain. It went away. 6 days after the initial shot, I woke up in excruciating pain. I went to the ER. They performed all kinds of tests while at the ER. I was diagnosed acute pancreatitis. I should still be at the hospital, but we had a death in the family so I came home. I was in the hospital for 2 days.
This spontaneous report was received from a medical assistant refers to a patient of unknown age. On an unknown date, the patient was vaccinated with improperly stored doses of VARIVAX, (lot # M000996, expiry date 07-JAN-2018. No adverse reactions were reported. Additional information has been requested.
Patient reports her arm started to swell and get what looked like a rash day of vaccination.  By the next morning, patient states entire upper arm was red, HOT, swollen, and still had a rash. Patient reports additional symptoms of severe exhaustion, inability to sit up for longer than a few minutes without extreme dizziness, fever, achy and painful joints, back pain, ear pain, headache, nausea, feeling like she was going to pass out, severe arm pain. These symptoms lasted for 4 days and the most severe day was the day after the vaccines were administered.
Information has been received from a registered nurse concerning a 24 year old female with sulfonamide allergy and allergic reaction to antibiotics who on 14-FEB-2007 was vaccinated intramuscularly with Gardasil (yeast) (0.5 ml). On 17-FEB-2007 the patient developed facial redness, malaise and an intermittent widespread rash. The patient was evaluated at a local emergency room and prescribed a course of steroids. The patient was not hospitalized. The patient fully recovered (date unspecified). Additional information has been requested.
1) Chills - cold, shaking. Began at 8:00pm lasted until 12am 2) Fever - 100F fever, began at 8:00pm lasted until 3am 3) Arm Pain at Injection Site - Began at 8:00pm, current
Early June 2021- Tingling on forehead and scalp developed in to debilitating case of shingles on left side scalp, forehead and eye.- 6months. (June- December) Developed herpetic neuralgia-6months still experience severe  migraine like pain and eye dryness/scratchiness.   December 2021- began collapsing  with one or two occurrences a day. Debilitating.  Injured myself on multiple occasions. Including a broken nose.  I went to my doctor multiple times, wore a heart holter. Went to infectious disease doctor, then cardiologist. Spent time in the hospital for 5 days for extensive tests and monitoring in December 2022 after months of inconclusive results was referred to a specialty cardiologist /electrophysiologist and diagnosed with POTS. Immediately began treatment with medication and just this past month April 2023 was put on medication with with adjusted dose age.
Pt vaccinated with DTP/HBOC cried "all day" high pitched for more than 3 hrs, refused to nurse. No fever, no limpness or paleness.  Fine next day. Used tylenol
After last vaccine was given child stated to her mother that she felt light headed.  Mother stated that the child looked pale , I took a blood pressure , it was low so I assisted the child to the supine position and elevated her feet.  The child continued to play a game on her phone but stated that she still felt lightheaded.  I took another blood pressure which was in the range of the child's normal blood pressure according to the mom.  I assisted the child to the sitting position and took another blood pressure and noted that the child's skin color had returned. I offered the child some hard candy and she consumed it.  I assisted the child to a standing position and she stated that she feels much better and able to leave.  I walked the child and mother to the front without assistance.
VACCINE EXPOSURE DURING PREGNANCY; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (VACCINE EXPOSURE DURING PREGNANCY) in a 36-year-old female patient (gravida 10, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M2-0A and 025121A) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism and Live birth on 23-Aug-2015. Concomitant products included HYDROXYCHLOROQUINE, VITAMIN D NOS, ACETYLSALICYLIC ACID (ASPIRIN ANALGESIC), DOXYLAMINE SUCCINATE (UNISOM [DOXYLAMINE SUCCINATE]) and VITAMIN B6 for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 31-Jul-2020 and the estimated date of delivery was 22-Apr-2021. On 06-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (VACCINE EXPOSURE DURING PREGNANCY). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-seventh week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 06-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (VACCINE EXPOSURE DURING PREGNANCY) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Aug-2020, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. It was reported that there was maternal history of subfertility  Also, This was an in-vitro fertilization. It was reported that the consumer had 9 miscarriages (spontaneous abortions) No complications or acute illness were reported during this pregnancy to date. There was no family history of congenital anomalies/ genetic disease. The prior use of alcohol was reported by the consumer. The laboratory tests were reported as:  On an unknown date, Ultrasound at 7 weeks and genetic testing of embryo before implantation were reported. Estimated date of conception was reported as 31-JUL-2020.
Low grade fever, body aches, chills, swollen, reddened, knotted area at the injection site approximately 4 inches in diameter
Patient presented with complaint of pain in left arm, shoulder to elbow (ache), which causes a sharp pain when attempting to raise arm above his head. Patient says this is ongoing from 10/23/13 to today, 1/8/14. Patient has not sought treatment.
It was reported that an 18 year old male pt received a Menomune A/C/Y/W-135 vaccination on 6/2/00. Reportedly, on 6/13/00, the pt developed a possible sterile abscess, no specifics provided. Further information requested.
Patient admitted with massive portal vein thrombosis and low plt in setting of infection. Symptoms started one week prior
Patient presented and said she needed "booster", so bivalent COVID vaccine was given.  Upon further review, patient had only had one dose in the primary series, and needed the second dose in the primary series.  Moderna was contacted. Recommended to follow CDC recommendations to give second dose with no minimum interval. Patient had no reaction to medication. Patient informed to receive second dose at their convenience.
the spot of redness is probably about the soft ball size; its hot,  I touch it, its very warm; its itchy; Redness; heat; the ecthyma those symptoms around the injection site; booster; little bit of pain; Swelling; Injection site pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administration date 05Nov2021 15:30 (Lot number: FF8839, Expiration Date: Dec2021) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "headache" (unspecified if ongoing), notes: Just an occasional Tylenol for headache every once in a while. Concomitant medication(s) included: TYLENOL taken for headache. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 05Nov2021 15:30, outcome "unknown", described as "little bit of pain"; VACCINATION SITE MASS (non-serious), outcome "unknown", described as "the spot of redness is probably about the soft ball size"; VACCINATION SITE WARMTH (non-serious), outcome "not recovered", described as "its hot, I touch it, its very warm"; ECTHYMA (non-serious) with onset 06Nov2021, outcome "unknown", described as "the ecthyma those symptoms around the injection site"; IMMUNISATION (non-serious) with onset 05Nov2021 15:30, outcome "unknown", described as "booster"; VACCINATION SITE PAIN (non-serious) with onset 05Nov2021, outcome "not recovered", described as "Injection site pain"; VACCINATION SITE ERYTHEMA (non-serious) with onset 06Nov2021, outcome "not recovered", described as "Redness"; VACCINATION SITE SWELLING (non-serious) with onset 05Nov2021, outcome "not recovered", described as "Swelling"; FEELING HOT (non-serious) with onset 06Nov2021, outcome "not recovered", described as "heat"; VACCINATION SITE PRURITUS (non-serious), outcome "unknown", described as "its itchy".  Additional information: it was reported patient having an adverse reaction to my third shot of COVID vaccine. Stated since the vaccination have had injection site pain, and redness and swelling and heat and so she is now here on November 8th at 6pm and still have that. So and beside the redness and its itchy, the size of the spot of redness is probably about the soft ball size. Also reported ecthyma those symptoms around the injection site started on the night on Saturday, so she got the shot she had of course little bit of pain when se got it but the redness and the heat and everything around it started on the night on Saturday. She expected it for a day or 2 but now several day passed and she really shocked by how much, mean its hot, se touch it, its very warm.  Follow-up attempts are completed. No further information is expected.